October 24, 2007

SpeculatingStocks.com Stock Pick: Arrhythmia Research Technology, Inc. (HRT)

Stock Price: $9.51 (short-term)

Arrhythmia Research Technology, Inc. licenses medical software that acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias. Its products consist of signal-averaging electrocardiographic software, whose proprietary Windows based version is named the Predictor series.

HRT is trading at a market cap of only $25.78 million. We believe it is drastically undervalued based on their proprietary technology and past financial performance.

HRT has grown revenues from $11.11 million in 2004 to $12.89 million in 2005 to $19.31 million in 2006. Net income was $1.61 million, $1.57 million and $2.16 million over the same period.

HRT has a clean balance sheet with total assets exceeding total liabilities by a ratio of over 8 to 1.

HRT just touched oversold and has support just below its current price if it needs it. We believe HRT has nice potential to move before year end.